DAKOTA JUDDS: Open Payments
NPI 1669106704 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $595 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $187 |
| Novo Nordisk Inc | 4 | $76 |
| Astellas Pharma US Inc | 1 | $34 |
| Nalu Medical, Inc. | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, Ozempic, QULIPTA, UBRELVY, ELIQUIS, Veozah, Nalu Neurostimulation System, SPRAVATO.
Industry payments across NE — which companies pay providers there.
